Samuel Gebhardt

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Roche (Switzerland)29.5%
• DecImmune Therapeutics (United States)13.9%
• Roche Pharma AG (Germany)10.8%
• Light Chain Bioscience (Switzerland)10.8%
• Azienda Ospedaliera Citta' della Salute e della Scienza di Torino6%
• Clinica Universidad de Navarra5.4%
• Other23.5%

Fields

• Medicine92.3%
• Immunology and Microbiology7.7%

Topics

• CAR-T cell therapy research23.1%
• Monoclonal and Polyclonal Antibodies Research17.9%
• Cancer Immunotherapy and Biomarkers15.4%
• Lymphoma Diagnosis and Treatment10.3%
• Immune Cell Function and Interaction10.3%
• Immunotherapy and Immune Responses7.7%
• Other15.4%